中文 | English
Return
Total: 15 , 1/2
Show Home Prev Next End page: GO
Author:(H ZOU)

1.Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Michael H. LE ; Yee Hui YEO ; Biyao ZOU ; Scott BARNET ; Linda HENRY ; Ramsey CHEUNG ; Mindie H. NGUYEN

Clinical and Molecular Hepatology 2022;28(4):841-850

2.Analysis of Drug Use for Rare Gefitinib-caused Liver Injury Complicated with Cholecystitis in a Patient with Lung Adenocarcinoma by Clinical Pharmacists

Yufang LIAO ; Ze ZOU ; Jiannong YUE

China Pharmacy 2020;31(20):2546-2550

5.Activation of HIF-1α/ACLY signaling axis promotes progression of clear cell renal cell carcinoma with VHL inactivation mutation.

Y MA ; Y H WANG ; S HUANG ; Z G ZOU ; L HU ; L C GUO

Chinese Journal of Pathology 2023;52(12):1230-1236

6.Analysis on voluntary blood donation and associated factors in men who have sex with men in 3 cities in China.

X J MENG ; T J JIA ; H L YIN ; Z Z LUO ; Y DING ; W Y CHEN ; S J HUANG ; H P ZHENG ; B YANG ; A GRULICH ; Y LU ; Z Y WANG ; Y H QIAN ; H C ZOU

Chinese Journal of Epidemiology 2018;39(11):1443-1448

8.Impact of the 90-90-90 goal and pre-exposure prophylaxis on HIV transmission and elimination in men who have sex with men in China: A mathematical modeling study.

K R WANG ; L P PENG ; J GU ; C HAO ; H C ZOU ; Y T HAO ; J H LI

Chinese Journal of Epidemiology 2018;39(11):1507-1514

9.Subjective Well-being and Family Functioning among Adolescents Left Behind by Migrating Parents in Jiangxi Province, China.

Jia ZHOU ; Fang HU ; Jing WU ; Zhi Yong ZOU ; Yi Xin WANG ; Hua Can PENG ; Sten H VERMUND ; Yi Fei HU ; Ying Hua MA

Biomedical and Environmental Sciences 2018;31(5):382-388

10.Preparation and in vitro evaluation of FDM 3D printed theophylline tablets with personalized dosage.

A KAIDIERYA ; R G ZHANG ; H N QIAN ; Z Y ZOU ; Y DANNIYA ; T Y FAN

Journal of Peking University(Health Sciences) 2022;54(6):1202-1207

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 15 , 1/2 Show Home Prev Next End page: GO